Yarrow Bioscience, Inc.
PublicYarrow Bioscience, Inc. is now publicly traded
The data on this page reflects Yarrow Bioscience, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series A
Dec 18, 2025
Total Funding Raised
$300M
Company Overview
Yarrow Bioscience, Inc. has raised $300M. It was founded in 2025.
Yarrow Bioscience, Inc. is a biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, including Graves' disease and thyroid eye disease.
AI Layer
Non-AI
Yarrow Bioscience, Inc. Comparables
Compare Yarrow Bioscience, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AV7 Limited | 90% | |
| Ollin Biosciences | 80% | |
| Regeneron Pharmaceuticals | 80% |
For institutional investors. Book with your work email.
Yarrow Bioscience, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Series A | Dec 17, 2025 |
For institutional investors. Book with your work email.
Yarrow Bioscience, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A |
| LifeSci Venture Partners | Series A |
| Perceptive Advisors | Series A |
| OrbiMed | Series A |
| Logos Capital | Series A |
| venBio | Series A |
| RTW Investments | Series A |
Recent news
Latest coverage and updates
- has_revenueSep 13, 2026
Yarrow Bioscience, Inc. has $100K in revenue for the quarter, compared with a $0.20 million consensus estimate.
- receives_financingSep 11, 2026
Connecticut-based Yarrow Bioscience, Inc. announces pricing of a $150M underwritten public offering on Sep 11th '26, with Jefferies, TD Cowen and Guggenheim Securities as joint book-running managers and LifeSci Capital as lead manager; the offering is expected to close on Sep 14th '26, and proceeds fund research and development and general corporate purposes.
For institutional investors. Book with your work email.
Yarrow Bioscience, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.